Drug administrator cautions use of nimesulide

By Cai Wenjun | February 15, 2011, Tuesday |

Online Edition

SHANGHAI Food and Drug Administration officials said today that they will tighten supervision over the use of nimesulide, an anti-inflammatory drug that has effects on acute pain and fever caused by respiratory tract infection.

Thousands of side effects and even several death cases had been reported involving Chinese children who took the drug.

Local pediatric hospitals said nimesulide, a prescribed medicine, is not a priority fever drug in clinical practice because it is harmful to the central nerve system and to the liver. Local hospitals will strengthen control of the drug.

Parents are also warned about the drug's potential risks when they buy fever medicines at drugstores.

Health and Science

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Drug administrator cautions use of nimesulide

Email this to your friend